Long-term outcomes of the pentaspline pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation: results of the prospective, multicentre FARA-Freedom Study.
Journal Information
Full Title: Europace
Abbreviation: Europace
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest: We have read the journal’s policy, and the authors of this manuscript have the following competing interests: Authors have served as consultants and received lecture honoraria or research grants from multiple industry partners, including Boston Scientific (the trial sponsor), Biosense Webster, Medtronic, Abbott, Lifetech, Bayer, and Bristol Myers Squibb. Additionally, the following are employees of the sponsor: A.V., A.B.A., M.J., and J.D.R."
"Funding This study was funded by Boston Scientific Corporation."
"Registration: Clinical Trials.gov Identifier: NCT05072964 (sponsor: Boston Scientific Corporation)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025